Combinati Incorporated

&A

Software for use in detecting cancer and infectious disease; software for use in prenatal screenings, namely, software for capturing optical images and performing image analysis; software for use in operating quantitative polymerase chain reaction (PCR) instruments; polymerase chain reaction (PCR) instruments for use in scientific research, namely, laboratory apparatus and instruments for amplifying DNA using polymerase chain reaction (PCR); scientific research instruments for use in measuring and quantifying copy number of DNA;AND A;Medical devices for detection of cancer; medical devices for detection of infectious disease, namely, digital polymerase chain reaction (PCR) platform; medical devices for use in pre-natal screenings, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, polymerase chain reaction (PCR) instruments for use in detecting, diagnosing and treating cancer and infectious disease, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, polymerase chain reaction (PCR) instruments for use in pre-natal screenings, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, instruments for use in measuring and quantifying copy number of DNA for medical diagnostic purposes, namely, digital polymerase chain reaction (PCR) platform;Providing temporary use of non-downloadable computer software for use in detecting cancer and infectious disease; providing temporary use of non-downloadable computer software for use in prenatal screenings, namely, non-downloadable software for capturing optical images and performing image analysis; providing temporary use of non-downloadable computer software for use in operating quantitative polymerase chain reaction (PCR) instruments;

ABSOLUTE

Laboratory equipment, namely, microfluidic array plates and optical detection apparatus in the nature of a laboratory instrument for the detection of nucleic acid molecules in a biological sample for research use;Kits consisting primarily of medical diagnostic reagents and laboratory equipment being microfluidic array plates for medical use; clinical medical diagnostic reagents being oligonucleotides, primers, enzymes and reaction buffers, sold individually, for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription polymerase chain reaction for use in clinical laboratories, hospitals, point-of-care and direct consumer applications; medical diagnostic kits consisting primarily of clinical medical reagents being oligonucleotides, enzymes, and nucleotides, and also containing DNA primers and biochemical probes, fluorescent reference dye, and reaction buffers for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription polymerase chain reaction for use in clinical laboratories, hospitals, point-of-care and direct consumer applications;Kits consisting primarily of laboratory and scientific reagents and laboratory equipment being microfluidic array plates for laboratory and scientific research use, other than for medical or veterinary use; laboratory reagents for scientific and research use, namely, oligonucleotides, DNA primers and biochemical probes for detecting and analyzing molecules in protein or nucleotide arrays, enzymes and enzyme mix substrates, nucleotide sets and nucleotide mixes both consisting primarily of nucleotides for scientific and research use, fluorescent reference dye, reaction buffers, sold individually and also sold together as a kit, for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription polymerase chain reaction, all of the foregoing for laboratory, scientific and research use;

ABSOLUTE Q

Polymerase chain reaction (PCR) instruments for use in scientific research, namely, laboratory apparatus and instruments for amplifying DNA using polymerase chain reaction (PCR); scientific research instruments for use in measuring and quantifying copy number of DNA;Medical devices for detection of cancer; medical devices for detection of infectious disease, namely, digital polymerase chain reaction (PCR) platform; medical devices for use in pre-natal screenings, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, polymerase chain reaction (PCR) instruments for use in detecting, diagnosing and treating cancer and infectious disease, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, polymerase chain reaction (PCR) instruments for use in pre-natal screenings, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, instruments for use in measuring and quantifying copy number of DNA for medical diagnostic purposes, namely, digital polymerase chain reaction (PCR) platform;

ABSOLUTE Q

Laboratory equipment, namely, microfluidic array plates and optical detection apparatus in the nature of a laboratory instrument for the detection of nucleic acid molecules in a biological sample for research use;Kits consisting primarily of medical diagnostic reagents and laboratory equipment being microfluidic array plates for medical use; clinical medical diagnostic reagents being oligonucleotides, primers, enzymes and reaction buffers, sold individually, for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription-polymerase chain reaction for use in clinical laboratories, hospitals, point-of-care and direct consumer applications; medical diagnostic kits consisting primarily of clinical medical reagents being oligonucleotides, enzymes, and nucleotides, and also containing DNA primers and biochemical probes, fluorescent reference dye, and reaction buffers for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription polymerase chain reaction for use in clinical laboratories, hospitals, point-of-care and direct consumer applications;Kits consisting primarily of laboratory and scientific reagents and laboratory equipment being microfluidic array plates for laboratory and scientific research use, other than for medical or veterinary use; laboratory reagents for scientific and research use, namely, oligonucleotides, DNA primers and biochemical probes for detecting and analyzing molecules in protein or nucleotide arrays, enzymes and enzyme mix substrates, nucleotide sets and nucleotide mixes both consisting primarily of nucleotides for scientific and research use, fluorescent reference dye, reaction buffers, sold individually and also sold together as a kit, for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription polymerase chain reaction, all of the foregoing for laboratory, scientific and research use;

COMBINATI

Software for use in detecting cancer and infectious disease; software for use in prenatal screenings, namely, software for capturing optical images and performing image analysis; software for use in operating quantitative polymerase chain reaction (PCR) instruments; polymerase chain reaction (PCR) instruments for use in scientific research, namely, laboratory apparatus and instruments for amplifying DNA using polymerase chain reaction (PCR); scientific research instruments for use in measuring and quantifying copy number of DNA;The English translation of COMBINATI in the mark is COMBINED.;Medical devices for detection of cancer; medical devices for detection of infectious disease, namely, digital polymerase chain reaction (PCR) platform; medical devices for use in pre-natal screenings, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, polymerase chain reaction (PCR) instruments for use in detecting, diagnosing and treating cancer and infectious disease, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, polymerase chain reaction (PCR) instruments for use in pre-natal screenings, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, instruments for use in measuring and quantifying copy number of DNA for medical diagnostic purposes, namely, digital polymerase chain reaction (PCR) platform;

|Q|

Polymerase chain reaction (PCR) instruments for use in scientific research, namely, laboratory apparatus and instruments for amplifying DNA using polymerase chain reaction (PCR); scientific research instruments for use in measuring and quantifying copy number of DNA;Medical devices for detection of cancer; medical devices for detection of infectious disease, namely, digital polymerase chain reaction (PCR) platform; medical devices for use in pre-natal screenings, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, polymerase chain reaction (PCR) instruments for use in detecting, diagnosing and treating cancer and infectious disease, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, polymerase chain reaction (PCR) instruments for use in pre-natal screenings, namely, digital polymerase chain reaction (PCR) platform; medical devices, namely, instruments for use in measuring and quantifying copy number of DNA for medical diagnostic purposes, namely, digital polymerase chain reaction (PCR) platform;

|Q|

Laboratory equipment, namely, microfluidic array plates and optical detection apparatus in the nature of a laboratory instrument for the detection of nucleic acid molecules in a biological sample for research use;Kits consisting primarily of medical diagnostic reagents and laboratory equipment being microfluidic array plates for medical use; clinical medical diagnostic reagents being oligonucleotides, primers, enzymes and reaction buffers, sold individually, for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription polymerase chain reaction for use in clinical laboratories, hospitals, point-of-care and direct consumer applications; medical diagnostic kits consisting primarily of clinical medical reagents being oligonucleotides, enzymes, and nucleotides, and also containing DNA primers and biochemical probes, fluorescent reference dye, and reaction buffers for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription polymerase chain reaction for use in clinical laboratories, hospitals, point-of-care and direct consumer applications;Kits consisting primarily of laboratory and scientific reagents and laboratory equipment being microfluidic array plates for laboratory and scientific research use, other than for medical or veterinary use; laboratory reagents for scientific and research use, namely, oligonucleotides, DNA primers and biochemical probes for detecting and analyzing molecules in protein or nucleotide arrays, enzymes and enzyme mix substrates, nucleotide sets and nucleotide mixes both consisting primarily of nucleotides for scientific and research use, fluorescent reference dye, reaction buffers, sold individually and also sold together as a kit, for nucleic acid genotyping, nucleic acid quantification and nucleic acid amplification, and polymerase chain reaction and reverse transcription polymerase chain reaction, all of the foregoing for laboratory, scientific and research use;